Pune, India -- (SBWIRE) -- 05/11/2018 -- Global transradial access market is expected to reach USD 2,061.8 Million by 2025 from USD 1,105.8 Million in 2017, at a CAGR of 8.2% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Competitive Analysis: Global Transradial Access Market

The global transradial access market analysis is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of transradial access market for global, Europe, North America, Asia Pacific and South America.

To request a free sample copy or view summary of this report, click the link below @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-transradial-access-market

The key market players for global transradial access market are listed below:

- BD
- Terumo Corporation
- Teleflex Incorporated
- Smiths Group plc
- MEDTRONIC
- Boston Scientific Corporation
- Edwards Lifesciences Corporation
- Merit Medical Systems Inc.
- NIPRO CORPORATION, ANGIODYNAMICS INC.
- Amecath
- OSCOR Inc.
- Penumbra
- Stryker
- CARDINAL HEALTH

Covered in this report

The report covers the present scenario and the growth prospects of the global transradial access for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Any specific requirements are you looking for? Ask to your Industry Experts @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-transradial-access-market

Market is further segmented into:
- Product
- Application
- Usage
- End User

The global transradial access market is segmented based on product into six notable segments; sheaths and sheath introducers, mircrocatheters, guidewires, guiding catheters, intermediate catheters and accessories. In 2018, sheaths and sheath introducers market is likely to dominate market with 29.5% shares and is estimated to reach USD 643.90 million by 2025. It is growing at the highest CAGR of 9.1% in the forecast period.
The global transradial access market is segmented based on application into three notable segments; neurovascular, cardiology, and peripheral vascular. In 2018, cardiology market will dominate with 46.6% shares and will consume around USD 999.66 million by 2025. It is growing at the highest CAGR of 8.8% in the assessment period.

The global transradial access market is segmented based on usage into four notable segments; drug administration, fluid and nutrition administration, diagnostics and testing and blood transfusion. In 2018, the drug administration market is estimated to dominate market with 35.8% shares and will collect around USD 781.7 million by 2025, rising with the highest CAGR of 9.1%.

The global transradial access market is segmented based on end user into four notable segments; hospital, clinics, ambulatory care centers and others. In 2018, hospitals market is expected to dominate market with 41.5% shares and is estimated to reach USD 893.28 million by 2025, growing at the highest CAGR of 8.9%.

Based on geography, the market is segmented into 5 geographical regions:
- North America
- Europe
- Asia-Pacific
- South America
- Middle East and Africa

Browse Report Description @ http://databridgemarketresearch.com/reports/global-transradial-access-market/

TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL TRANSRADIAL ACCESS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 SECONDARY SOURCES
2.8 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 INCREASING CASES OF OBESE PATIENTS
3.1.2 RISING NUMBER OF HEART PROBLEMS
3.1.3 GROWING USE OF RADIAL ACCESS IN ONCOLOGY FIELD
3.1.4 TECHNOLOGICAL ADAVANCEMENTS
3.2 RESTRAINTS
3.2.1 PRODUCT RECALLS AND FAILURES
3.3 OPPORTUNITIES
3.3.1 EMERGING MARKETS
3.4 CHALLENGES
3.4.1 SIDE EFFECTS OF TRANSRADIAL ACCESS
3.4.2 LACK OF SKILLED PROFESSSIONALS
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
?
6 GLOBAL TRANSRADIAL ACCESS MARKET, BY PRODUCT
6.1 OVERVIEW
6.2 SHEATHS AND SHEATH INTRODUCERS
6.3 MIRCROCATHETERS
6.4 GUIDEWIRES
6.5 GUIDING CATHETERS
6.6 INTERMEDIATE CATHETERS
6.7 ACCESSORIES
7 GLOBAL TRANSRADIAL ACCESS MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 CARDIOLOGY
7.3 PERIPHERAL VASCULAR
7.4 NEUROVASCULAR
8 GLOBAL TRANSRADIAL ACCESS MARKET, BY USAGE
8.1 OVERVIEW
8.2 DRUG ADMINISTRATION
8.3 FLUID AND NUTRITION ADMINISTRATION
8.4 DIAGNOSTICS AND TESTING
8.5 BLOOD TRANSFUSION
9 GLOBAL TRANSRADIAL ACCESS MARKET, BY END USER
9.1 OVERVIEW
9.2 HOSPITAL
9.3 CLINICS
9.4 AMBULATORY CARE CENTERS
9.5 OTHERS
10 GLOBAL TRANSRADIAL ACCESS SYSTEM MARKET, BY GEOGRAPHY
10.1 OVERVIEW
10.2 NORTH AMERICA
10.2.1 U.S.
10.2.2 CANADA
10.2.3 MEXICO
10.3 EUROPE
10.3.1 GERMANY
10.3.2 FRANCE
10.3.3 U.K.
10.3.4 ITALY
10.3.5 SPAIN
10.3.6 SWITZERLAND
10.3.7 NETHERLANDS
10.3.8 TURKEY
10.3.9 BELGIUM
10.3.10 RUSSIA
10.3.11 REST OF EUROPE
10.4 ASIA- PACIFIC
10.4.1 JAPAN
10.4.2 CHINA
10.4.3 INDIA
10.4.4 SOUTH KOREA
10.4.5 AUSTRALIA
10.4.6 SINGAPORE
10.4.7 THAILAND
10.4.8 MALAYSIA
10.4.9 INDONESIA
10.4.10 PHILIPPINES
10.4.11 REST OF ASIA-PACIFIC
10.5 SOUTH AMERICA
10.5.1 BRAZIL
10.5.2 REST OF SOUTH AMERICA
10.6 MIDDLE EAST AND AFRICA
10.6.1 SOUTH AFRICA
10.6.2 REST OF MIDDLE EAST AND AFRICA
11 GLOBAL TRANSRADIAL ACCESS MARKET, COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: GLOBAL
11.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
11.3 COMPANY SHARE ANALYSIS: EUROPE
11.4 COMPANY SHARE ANALYSIS: ASIA PACIFIC
?
12 COMPANY PROFILES
12.1 CARDINAL HEALTH
12.1.1 COMPANY OVERVIEW
12.1.2 REVENUE ANALYSIS : CARDINAL HEALTH
12.1.3 PRODUCT PORTFOLIO
12.1.7 RECENT DEVELOPMENTS RECENT DEVELOPMENTS
12.2 STRYKER
12.2.1 COMPANY OVERVIEW
12.2.2 REVENUE ANALYSIS: STRYKER
12.2.3 PRODUCT PORTFOLIO
12.2.7 RECENT DEVELOPMENTS
12.3 ANGIODYNAMICS INC
12.3.1 COMPANY OVERVIEW
12.3.2 REVENUE ANALYSIS : ANGIODYNAMICS INC
12.3.3 PRODUCT PORTFOLIO
12.3.7 RECENT DEVELOPMENTS
12.4 BD
12.4.1 COMPANY OVERVIEW
12.4.2 REVENUE ANALYSIS : BD
12.4.3 PRODUCT PORTFOLIO
12.4.7 RECENT DEVELOPMENTS
12.5 AMECATH
12.5.1 COMPANY OVERVIEW
12.5.2 COMPANY SNAPSHOT: AMECATH
12.5.3 PRODUCT PORTFOLIO
12.5.4 RECENT DEVELOPMENTS
12.6 BOSTON SCIENTIFIC CORPORATION
12.6.1 COMPANY OVERVIEW
12.6.2 REVENUE ANALYSIS : BOSTON SCIENTIFIC CORPORATION
12.6.3 PRODUCT PORTFOLIO
12.6.4 RECENT DEVELOPMENTS
12.7 EDWARDS LIFESCIENCES CORPORATION
12.7.1 COMPANY OVERVIEW
12.7.2 REVENUE ANALYSIS : EDWARDS LIFESCIENCES CORPORATION
12.7.3 PRODUCT PORTFOLIO
12.7.4 RECENT DEVELOPMENTS
12.8 MEDTRONIC
12.8.1 COMPANY OVERVIEW
12.8.2 REVENUE ANALYSIS : MEDTRONIC
12.8.3 PRODUCT PORTFOLIO
12.8.4 RECENT DEVELOPMENTS
12.9 MERIT MEDICAL SYSTEMS INC.
12.9.1 COMPANY OVERVIEW
12.9.2 REVENUE ANALYSIS: MERIT MEDICAL SYSTEMS INC.
12.9.3 PRODUCT PORTFOLIO
12.9.4 RECENT DEVELOPMENTS
12.10 NIPRO CORPORATION
12.10.1 COMPANY OVERVIEW
12.10.2 REVENUE ANALYSIS : NIPRO CORPORATION
12.10.3 PRODUCT PORTFOLIO
12.10.4 RECENT DEVELOPMENTS
12.11 OSCOR INC
12.11.1 COMPANY OVERVIEW
12.11.2 COMPANY SNAPSHOT: OSCOR INC:
12.11.3 RODUCT PORTFOLIO
12.11.4 RECENT DEVELOPMENTS
12.12 PENUMBRA
12.12.1 COMPANY OVERVIEW
12.12.2 REVENUE ANALYSIS: PENUMBRA
12.12.3 PRODUCT PORTFOLIO
12.12.4 RECENT DEVELOPMENTS
12.13 SMITHS GROUP PLC
12.13.1 COMPANY OVERVIEW
12.13.2 REVENUE ANALYSIS : SMITHS GROUP PLC
12.13.3 PRODUCT PORTFOLIO
12.13.4 RECENT DEVELOPMENTS
12.14 TELEFLEX INCORPORATED
12.14.1 COMPANY OVERVIEW
12.14.2 REVENUE ANALYSIS : TELEFLEX INCORPORATED
12.14.3 PRODUCT PORTFOLIO
12.14.4 RECENT DEVELOPMENTS
12.15 TERUMO CORPORATION
12.15.1 COMPANY OVERVIEW
12.15.2 REVENUE ANALYSIS : TERUMO CORPORATION
12.15.3 PRODUCT PORTFOLIO
12.15.4 RECENT DEVELOPMENTS RECENT DEVELOPMENTS
13 RELATED REPORTS

Browse Detailed TOC, Tables and Figures @ http://databridgemarketresearch.com/toc/?dbmr=global-transradial-access-market

Related Report

North America Telehealth Market – Industry Trends and Forecast to 2024

North America Telehealth Market, By Hardware (Telehealth Monitors, Monitoring Devices), By Software (Standalone, Integrated), By Services (Remote, Real Time, Store and Send), By Deployment (Web Based, Cloud Based, On Premise), By End-User (Healthcare Payers, Healthcare Providers, Patients), By Country (U.S., Canada, Mexico) – Industry Trends and Forecast to 2024

Report Access: http://databridgemarketresearch.com/reports/north-america-telehealth-market/

About Data Bridge Market Research
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com